BIOA vs CRON
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
BIOA
CRON
Investment Advisor Scores
CRON
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BIOA | CRON | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 22.3714 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -85.5% | 74.6% | CRON |
| Earnings Growth | 0.0% | -41.0% | BIOA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.5/100 | 50.5/100 | CRON |
| Profit Margin | 0.0% | 28.0% | CRON |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | CRON |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BIOA
NeutralMixed signals - no dominant trend phase, RSI 48
CRON
MarkupPrice above SMA50, rising 50-day trend (1.9% over 20 days), RSI 54
Fundamentals Snapshot
| Metric | BIOA | CRON |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -2.3 | 13.3 |
| Trailing P/E | — | 21.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | 0.7% |
| Gross Margin | -10.6% | 0.5% |
| Operating Margin | -125.5% | 0.1% |
| EPS | -2.56 | 0.16 |
| Dividend Yield | — | — |